Key points are not available for this paper at this time.
You have accessJournal of UrologyProstate Cancer: Epidemiology all p-value <0.001. CONCLUSIONS: The termination rate of urological cancer clinical trials was 25%, with low accrual being the most frequently reported reason. Trials funded by a university, single-center trials, and small trials (sample size <50) were associated with early termination. A better understanding of these factors might help researchers, funding agencies, and other stakeholders to prioritize resource allocations for multicenter trials that aim to recruit sufficient number of patients. Download PPT Source of Funding: No funding © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e1111 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Abdulrahman Alhajahjeh More articles by this author Layla El-amayreh More articles by this author David I. Lee More articles by this author Bashir Al Hussein Al Awamlh More articles by this author Mohammed Shahait More articles by this author Expand All Advertisement PDF downloadLoading ...
Alhajahjeh et al. (Mon,) studied this question.